Financial intelligence for Asia's healthcare markets
Remember me:

Japan: IHC sells ¥10 billion three-year FRNs to Shinsei Bank

International Healthway Corporation (IHC), a Singapore-listed integrated healthcare services and facilities provider, has solved the sword of Damocles of its Japanese financing. It has sold ¥10 billion (US$88.2 million) three-year floating rate notes at three-month yen Libor plus 1.03% to regular supporter Shinsei Bank.

Proceeds will be used to refinance IHC’s outstanding TMK bonds. These carried a floating interest rate of three-month yen Libor plus 3.20%, and so the group has cut 217bp off its borrowing costs.

IHC owns 12 nursing homes and one annex in Japan. Their acquisition  was initially partially funded through the issuance of TMK bonds in 2013, and refinanced via further TMK bonds in 2016. That paper was entirely taken by Shinsei. In January this year, IHC agreed a three-year mezz loan of up to ¥8 billion with a “major international” unnamed bank to help refinance the 2019 TMK bonds.

This now completes IHC’s ¥18 million financing needs for the year.

TMKs or tokutei mokuteki kaisha are a form of Japanese corporation that is taxed like a REIT and used to hold property in Japan. Under their structure they must issue bonds or preferred shares.

Posted on: 14/07/2017 UTC+08:00


Shares in Sisram Medical, a Israeli subsidiary of Shanghai Fosun Pharmaceutical, and which manufactures medical aesthetics devices, slumped on their Hong Kong Stock Exchange debut today. By late morning they were down more than 6%.
Auckland-based ehealth software company Orion Health has signed a five-year contract with Integrated Health Information Systems (IHiS), the health technology agency for Singapore.
Irish healthcare, IT and services company Clanwilliam Group has taken a majority shareholding in HealthLink, Australasia’s leading health-system integrator. Financial terms have not been disclosed.
Strategic initiatives and expansion have driven a rise in first quarter profits at iKang Healthcare Group, China’s largest private preventive healthcare services provider.
Optiscan Imaging, which develops microscopic imaging technologies for medical markets, has announced an exclusive distribution agreement with Chinese based China Gate Scientific for the newest Optiscan preclinical research system, ViewnVivo.
Contract genomics organisation WuXi NextCODE has appointed Rob Brainin as executive vice president and chief operating officer. Brainin joins the company from Illumina, where he was vice president and general manager of life sciences and applied genomics.
Melbourne-based medtech company Novita Healthcare has appointed Bruce Higgins as chairman. He is an experienced non- executive director, chairman and former chief executive of both private and listed companies within Australia and internationally, spanning over 25 years in diverse companies ranging from engineering, manufacturing and professional services to larger contracting businesses.
In what is another setback for Perth-based digital healthcare operator Resapp, Médecins Sans Frontières/Doctors Without Borders has decided not proceed with its planned field evaluation of the group’s software. ResApp’s main product is a cough-based diagnostic test that works with a smartphone to analyse the sound of a patient’s cough and to diagnose any underlying conditions.


By 2042 there will be more over-65s in Asia than the populations of the Eurozone and North America combined. We look at the business opportunities this creates.
Albert Wong argues that biomedical technology should not be ignored and explains how the Hong Kong Science and Technology Parks Corporation can support it.
Jacob Pope explains why medical tourism remains one of the region’s most significant industries.
APACMed’s Fredrik Nyberg looks at how local and multinational IVD companies are developing novel solutions for Asia’s unique needs.
It is perhaps a curious line in the sand to draw, but the new hospital in Dunedin, the second-largest city in the South Island of New Zealand, is gearing up to be a significant battle in the use of private-public partnership funding in the APAC region.
The ADB’s Eduardo Banzon argues that ASEAN countries need to guarantee the same health coverage for citizens when they are in foreign countries.
Mercer’s Catherine Li explains how companies in China can avoid common pitfalls when they establish employee health management programmes.
Lieven Jacquemyn, PPP international development director at GE Healthcare Singapore, discusses how governments, providers and investors can work together to bring universal health coverage to the region.


HealthInvestor Asia Summit



Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices